Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Johannes Gaeseb"'
Autor:
Tariro Sithole, Gugu Mahlangu, Velma Capote, Tania Sitoie, Saren Shifotoka, Johannes Gaeseb, Lorraine Danks, Portia Nkambule, Alex Juma, Adam Fimbo, Zuma Munkombwe, Bernice Mwale, Sam Salek, Stuart Walker
Publikováno v:
Frontiers in Medicine, Vol 8 (2021)
Introduction: Regulatory reliance, harmonization and work sharing have grown over the last few years, resulting in greater sharing of work and information among regulators, enabling efficient use of limited resources and preventing duplication of wor
Externí odkaz:
https://doaj.org/article/d98144dbb5b74f8496b2b20f942e01b4
Autor:
Tariro Sithole, Gugu Mahlangu, Velma Capote, Tania Sitoie, Saren Shifotoka, Johannes Gaeseb, Silverani Padayachee, Tohlang Sehloho, Akida Khea, Adam Fimbo, Zuma Munkombwe, Bernice Mwale, Sam Salek, Stuart Walker
Publikováno v:
Frontiers in Medicine, Vol 8 (2021)
Introduction: National medicines regulatory agencies are faced with challenges including limited resources and technical capacity, resulting in countries collaborating and sharing resources to improve efficiency of the review process to facilitate ac
Externí odkaz:
https://doaj.org/article/0f7356289aab4d3b8e93bb94c6146e59
Autor:
Tafadzwa Tirivangani, BPharm, Bertha Alpo, BPharm, Dan Kibuule, BPharm; MSc; PhD, Johannes Gaeseb, BPharm; MPH, Babafunso A. Adenuga, BPharm; MPH; PhD
Publikováno v:
Exploratory Research in Clinical and Social Pharmacy, Vol 2, Iss , Pp 100037- (2021)
Background: Resilient pharmaceutical systems and supply chains are critical in the control of COVID-19, a pandemic that has mostly devastated public health systems and livelihoods in resource-limited countries in sub-Saharan Africa. Objective: To eva
Externí odkaz:
https://doaj.org/article/176357faa9ec4fb7bc0edb19b50aae25
Publikováno v:
Exploratory Research in Clinical and Social Pharmacy, Vol 2, Iss, Pp 100037-(2021)
Exploratory Research in Clinical and Social Pharmacy
Exploratory Research in Clinical and Social Pharmacy
Background Resilient pharmaceutical systems and supply chains are critical in the control of COVID-19, a pandemic that has mostly devastated public health systems and livelihoods in resource-limited countries in sub-Saharan Africa. Objective To evalu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e4178b24ffc99dc1191784b1e7a4b03
http://www.sciencedirect.com/science/article/pii/S2667276621000378
http://www.sciencedirect.com/science/article/pii/S2667276621000378
Autor:
Marita Mann, Greatjoy Mazibuko, Evans Sagwa, Assegid Mengistu, Andy Stergachis, Johannes Gaeseb, Jared M. Baeten, Joseph B. Babigumira, Louis P. Garrison
Publikováno v:
Pharmacoepidemiology and Drug Safety. 25:1052-1060
PURPOSE: Active surveillance pharmacovigilance systems better estimate the burden of adverse events (AEs) and can generate useful information on risk factors of AEs for more effective medicine use especially in conjunction with introduction of new me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::26e2795dd5969b46b2c2cb5e4a32cadf
https://doi.org/10.1002/pds.4022
https://doi.org/10.1002/pds.4022
Autor:
Greatjoy Mazibuko, Andy Stergachis, Johannes Gaeseb, Assegid Mengistu, Evans Sagwa, Louis P. Garrison, Joseph B. Babigumira, Marita Mann
Publikováno v:
Drug safety. 39(9)
Active surveillance pharmacovigilance is a systematic approach to medicine safety assessment and health systems strengthening, but has not been widely implemented in low- and middle-income countries. This study aimed to assess the cost effectiveness
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bdfbfc2e8ccc331f235ec8d7348a323c
https://pubmed.ncbi.nlm.nih.gov/27314405
https://pubmed.ncbi.nlm.nih.gov/27314405
Publikováno v:
Journal of Pharmaceutical Policy and Practice
Objectives In the management of HIV infection, tenofovir is preferred to its predecessors – zidovudine and stavudine – in the antiretroviral therapy (ART) nucleoside backbone. Tenofovir’s (TDF) preference is based on its safety profile. Neverth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6745d22f3ff81c247c51dc01f15af939
http://europepmc.org/articles/PMC4408595
http://europepmc.org/articles/PMC4408595
Publikováno v:
Journal of Pharmaceutical Policy and Practice
Background Clinical trials showed a higher risk of skin- and liver- related adverse reactions when NVP-based antiretroviral therapy (ART) was initiated in female and male patients with baseline CD4 cell counts ≥250 and ≥400, respectively. Some st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b467b31af6cac985a1d57c38028ef426
https://pubmed.ncbi.nlm.nih.gov/26881055
https://pubmed.ncbi.nlm.nih.gov/26881055
Publikováno v:
Enliven: Pharmacovigilance and Drug Safety.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::083145377fe0afa3fc179b971f1247f1
https://doi.org/10.18650/2378-5411.21002
https://doi.org/10.18650/2378-5411.21002
Autor:
Assegid Mengistu, Norbert Forster, Johannes Gaeseb, Gilbert Habimana, Saren Kauhondamwa, Gottfried Uaaka, Christophine Ndjavera, Emanuel Ugbaro, Lazarus Indongo, Evans Sagwa
Publikováno v:
Enliven: Pharmacovigilance and Drug Safety.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::be9c2623b53f945cbbdce8ddca6fd7af
https://doi.org/10.18650/2378-5411.13002
https://doi.org/10.18650/2378-5411.13002